PRA number
2019/17727
Published date
Product description
Endone oxycodone hydrochloride 5mg tablet blister pack
Batch Number: CW612
Expiry: Nov 2020
AUST R: 14945
Batch Number: CW612
Expiry: Nov 2020
AUST R: 14945
Why the product is recalled
A report has been received that a strip of 30mg Anamorph tablets may have been present in a box of 5mg Endone, post dispensing.
What the hazards are to consumers
Anamorph tablets are approximately four times the Endone equivalent dose, so there is the potential of serious health risks and overdose, if taken inadvertently.
What consumers should do
Consumers should visually inspect blister sheets to verify both blister strips contain Endone tablets. If a blister is identified with Anamorph printed on the back, do not use the tablets from that strip. Return strips of incorrect tablets to the chemist or pharmacy from which they were purchased.
Further information is available on the TGA website at: https://www.tga.gov.au/alert/endone-5-mg-tablets
For further information, contact Aspen Pharma by phone on 1300 659 646 or email at medical@aspenpharmacare.com.au
Further information is available on the TGA website at: https://www.tga.gov.au/alert/endone-5-mg-tablets
For further information, contact Aspen Pharma by phone on 1300 659 646 or email at medical@aspenpharmacare.com.au
Supplier
Traders who sold this product
Pharmacies and Chemists
Where the product was sold
Nationally
Responsible regulator
Therapeutic Goods Administration is the responsible regulator for this recall.